Cargando…
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?
BACKGROUND: Dual antiplatelet therapy and anticoagulants may be required in the case of coexistence of coronary artery disease and atrial fibrillation (AF) undergoing (PCI), with associated increased bleeding rates. The introduction of direct oral anticoagulants (DOACs), however, significantly reduc...
Autores principales: | Brunetti, Natale Daniele, Tricarico, Lucia, De Gennaro, Luisa, Correale, Michele, Santoro, Francesco, Ieva, Riccardo, Iacoviello, Massimo, Di Biase, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330069/ https://www.ncbi.nlm.nih.gov/pubmed/32637570 http://dx.doi.org/10.1016/j.ijcha.2020.100569 |
Ejemplares similares
-
Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018) -
Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019) -
SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century?
por: Correale, Michele, et al.
Publicado: (2023) -
Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks
por: Deitelzweig, Steve, et al.
Publicado: (2013) -
Atrial Fibrillation Ablation without Interruption of
Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)